Abstract
Three novel hybrid materials, SBA-15-RuValen, SBA-15-RuValpnol, and SBA-15-RuValdiamci, were obtained by immobilization of new [Ru(L)(PPh3)Cl] complexes (H2L = H2Valen, H2Valpnol, H2Valdiamci, are Schiff base proligands obtained by condensation of o-vanillin with ethylenediamine, 1,3-diamino-2-propanol, and 1,2-diaminocyclohexane, respectively) inside the mesoporous channels of SBA-15. [Ru(Valen)(PPh3)Cl]·3H2O (RuValen), [Ru(Valpnol)(PPh3)Cl]·3H2O (RuValpnol), and [Ru(Valdiamci)(PPh3)Cl]·4H2O (RuValdiamci) complexes were characterized by microanalysis (C,H,N), IR and UV–Vis spectroscopy, magnetic measurements. The structure of RuValen was also confirmed by single crystal X-ray diffraction. The hybrid materials were thoroughly characterized in terms of structure, composition, morphology, and textural properties. The results indicate the uniform distribution of Ru(III) complexes on the internal surface of SBA-15, the immobilization process having no significant influence on the structure of the support. The novel hybrid materials demonstrated high antibacterial and anti-biofilm activity against Enterococcus faecalis, Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli. In vitro tests regarding the cytotoxic effect on adenocarcinoma (HeLa) cells showed that all three hybrid materials decreased the cell viability in a dose-dependent manner, being very promising for medical applications.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
